The Coming Multi-State Operator Shakeout: Who Survives the Next Debt Wall

Photo by Igor Shalyminov via Unsplash.

Approximately $6 billion in cannabis operator debt hits maturity walls through the end of 2026, and the top five MSOs account for $3.4 billion of that load. This is not a forecast about what might happen—it is a description of what is actively happening right now. Ayr Wellness, a mid-tier operator with cultivation and retail assets across six states, executed a Restructuring Support Agreement on July 30, 2025, faced UCC Article 9 foreclosure of core assets in November 2025, and watched its equity holders get wiped out as senior noteholders became the winning bidders through a newly formed acquisition vehicle. That shakeout blueprint is now being executed in real time across the sector.

Federal prohibition creates a trap that traditional retailers never face. While a restaurant or retail chain struggling with debt maturity can file Chapter 11 bankruptcy in U.S. courts, cannabis operators cannot—federal law still classifies cannabis as Schedule I, which makes the plant itself contraband and disqualifies operators from bankruptcy protection. That leaves only one pressure valve: foreclosure and asset sale under UCC Article 9, the secured lending mechanism that strips equity holders and transfers ownership directly to creditors. Combine that with Section 280E, the tax code rule that prohibits cannabis companies from deducting cost of goods sold, and operators face compressed after-tax margins that make debt service harder every year the tax code stays unchanged.

The financing structure locked this in from the start. Debt comprised over 80 percent of all new capital raised in 2024-2025 cannabis financing rounds—not equity, not strategic partnerships, but debt. Operators became structurally dependent on refinancing into an increasingly hostile lending environment rather than raising fresh capital. Now the maturity walls have arrived, and the sorting mechanism is working exactly as the numbers predicted: operators who refinance early pay punitive rates but retain control; operators who wait or miss windows face the Ayr path.

The $6 Billion Wall: Why This Year Breaks Operators

Photo by Cht Gsml via Unsplash.

The $6 billion debt maturity wall through 2026 represents a refinancing bottleneck that will determine which operators control shelf space and cultivation capacity in 2027 and beyond. Of that total, the top five MSOs—Curaleaf, Verano, Jushi, Cresco Labs, and Trulieve—account for $3.4 billion. This concentration matters because it means a handful of operators are competing simultaneously for a finite pool of senior secured lending, and lenders, knowing they hold the power, have already begun pricing that scarcity into interest rates.

What makes 2026 different from prior years is not just the absolute size of the wall, but the structural conditions under which refinancing must occur. Section 280E remains in place as of March 2026 despite Trump's December 2025 executive order directing cannabis downgrade under federal law. The executive order directed the administrative process to move forward, but formal rescheduling—the legal mechanism that would allow operators to deduct cost of goods sold and restore 15-20 percent of after-tax cash flow—has not yet occurred. Operators must therefore refinance under current tax code, not a hypothetical future one. They carry the full weight of Section 280E compression into every negotiation with lenders.

Debt as a percentage of total capital raises tells the real story. In 2024-2025, over 80 percent of all new capital in cannabis financing rounds came from debt instruments: senior secured notes, convertible debt, and asset-based lending facilities. Equity raises dried up because publicly traded cannabis stocks remain illiquid and unprofitable on a cash-tax-adjusted basis. That leaves operators with only one way to fund operations and service existing debt: borrow more, at worse terms. They are trapped in a roll-forward cycle where refinancing is not an option but a necessity, and each refinancing round occurs at higher rates and tighter covenants.

Federal prohibition is the silent structural flaw that sets cannabis apart from every other distressed sector. A restaurant operator or retail chain with $50 million in debt maturing can file Chapter 11 bankruptcy, reorganize under court protection, cram down creditors, and potentially emerge with a fresh balance sheet. A cannabis operator cannot. The plant itself is Schedule I contraband under federal law, which means bankruptcy courts will not accept a cannabis business into Chapter 11. That leaves only UCC Article 9 foreclosure—a creditor-controlled mechanism that terminates equity, seizes assets, and auctions them to the highest bidder. There is no negotiation, no creditor committee, no chance for equity holders to retain partial ownership. Once foreclosure is triggered, equity is gone. This is not legal theory; it is exactly what Ayr Wellness experienced from July to November 2025.

The practical effect is that cannabis operators face a binary outcome when they miss a refinancing window: refinance on whatever terms lenders demand, or trigger foreclosure and lose everything. That binary choice is now forcing operators into increasingly expensive debt—11 to 12.5 percent interest rates that would be unthinkable for a comparable regulated business. Lenders know operators have no alternative, and operators know lenders have the structural advantage. The result is not efficient capital markets; it is a squeeze on operating margins from which only the largest and most disciplined operators will emerge intact.

Ayr's Collapse: The Blueprint for What's Coming

Photo by 12019 via Pixabay.

Ayr Wellness provides the operational blueprint for how the shakeout unfolds when an MSO fails to refinance on acceptable terms. On July 30, 2025, Ayr executed a Restructuring Support Agreement with its secured lenders—a formal acknowledgment that the company could not meet its debt obligations as due. That agreement outlined a path: the company would engage in an orderly UCC Article 9 foreclosure of its core assets, execute that sale within a defined timeline, and allow secured lenders to become the winning bidders.

What happened next is the mechanism the entire sector is now watching. From August through November 2025, Ayr's assets—retail licenses, cultivation facilities, and operating cash flow across Florida, New Jersey, Nevada, Ohio, Massachusetts, and Pennsylvania—were packaged for foreclosure. On November 10, 2025, those assets were auctioned. Senior noteholders, through a newly formed acquisition vehicle (known as NewCo), became the winning bidders. The outcome was not a restructured Ayr Wellness with new management and a lighter balance sheet. It was a complete transfer of ownership from equity holders to creditors. The previous shareholders—including founder Nick Ayers and early investors—were completely wiped out.

The NewCo ownership structure is crucial because it reveals the incentive structure lenders are now building into cannabis. A NewCo owned by debt holders has one mandate: paydown. It is not set up to expand, to take on new licenses, or to invest in competitive advantages. It is designed to generate quarterly cash flow and reduce debt. That means the Ayr that emerges from this process will be smaller, more disciplined, and focused on operational efficiency rather than market share. It will serve as a warning to other operators: refinance now, on whatever terms lenders demand, or your equity disappears entirely.

Ayr then filed under Canada's Companies' Creditors Arrangement Act (CCAA) on November 17, 2025, moving remaining non-core assets into cross-border restructuring. This is a deliberate use of Canadian law to retain operational flexibility outside U.S. bankruptcy court jurisdiction. While the UCC foreclosure was executed in the United States under state secured lending law, the CCAA filing allows Ayr to continue operating certain entities and potentially negotiate recoveries for unsecured creditors without federal interference. It is a two-step process: lose the U.S. equity through UCC foreclosure, then use Canadian bankruptcy law to preserve what operational assets remain. This hybrid approach is likely to become a template for other distressed U.S. cannabis operators.

Interim CEO Scott Davido publicly characterized the crisis not as a failure of Ayr's business model or management, but as an industry winnowing-out phase comparable to the 1900s consolidation of the cereal industry around Battle Creek, Michigan. That comparison is deliberate and worth taking seriously. Davido is signaling that this is not a Ayr-specific crisis—a failure of strategy or execution—but a sector-wide sorting mechanism. The debt structure, combined with federal prohibition and Section 280E, was always going to force consolidation. Ayr just hit the wall first, and loudly. Others are watching, adjusting, and racing to refinance before they hit their own maturity dates.

The Refinancing Winners: Rising Rates, Shrunken Choices

Photo by RDNE Stock project via Pexels.

The operators who refinanced early are now visible, and their refinancing rates reveal the true cost of waiting. In February 2026, Curaleaf priced a $500 million senior secured notes offering at 11.5 percent interest. This was explicitly to refinance $475 million due December 2026. Compare that to Curaleaf's prior issuance of similar-tenor debt at 8 percent, and the 350 basis point penalty for debt maturity risk becomes clear. Curaleaf had to choose: refinance months ahead of maturity at 11.5 percent, or risk Ayr's fate by waiting until the maturity deadline approached. The company chose the expensive option and locked in pain for the next five to seven years of debt service.

Verano Holdings took a different path but arrived at similar pain. In March 2026, the company secured $195 million from a consortium led by Needham Bank and Chicago Atlantic, priced at 9.5 percent interest, to refinance $350 million due the same year. The fact that Verano had to tap multiple lenders—rather than a single senior secured note placement—signals that debt markets for cannabis have fractured. Lenders are now willing to fund cannabis only when they can hold hard assets as collateral because unsecured equity risk is viewed as uninsurable. This shift from unsecured to asset-backed lending changes the negotiating power: lenders now demand liens on cultivation facilities, retail licenses, and operating cash accounts. Default becomes not a negotiation but an asset seizure.

Jushi Holdings refinanced $160 million at 12.5 percent in March 2026 through FocusGrowth Asset Management. This is the highest coupon among the major players who have reported refinancing, and it signals that lenders view Jushi's balance sheet risk as equivalent to late-stage venture funding—despite the fact that Jushi generates substantial operating cash flow from established, profitable dispensaries across multiple states. The 12.5 percent rate is not theoretical; it is what the market prices Jushi's refinancing risk at in March 2026. If Jushi's business deteriorates, if state regulations shift against its market positions, or if execution falters, that high coupon will not prevent foreclosure—it just means the lender took a bigger premium upfront to compensate for the risk they knew they were taking.

By March 2026, the refinancing scorecard among major operators told a story of winners and stragglers. Curaleaf and Jushi had completed large refinancings, securing capital through 2028-2029. Verano had closed its placement. Cresco Labs and Trulieve still had significant maturities on the calendar—Cresco with $400 million due in August 2026 and Trulieve with $390 million due later that year. The fact that these stragglers remained exposed meant they were either confident in their ability to refinance at the last moment, or they were hoping for regulatory relief (rescheduling, Section 280E fix) that might improve their negotiating position. Both are dangerous bets in a market where lenders hold all the structural power.

The pattern is now clear: operators who moved early and accepted high rates (Curaleaf at 11.5 percent, Jushi at 12.5 percent) bought themselves control and optionality through 2028-2029. They will hurt on debt service, but they own themselves. Operators who wait face Ayr's path: a race to refinance into a tightening market, and if they stumble, UCC foreclosure and equity wipeout. The debt wall has created a two-tier market: early-movers who refinance at punitive rates, and late-movers who risk losing ownership entirely.

Why Rescheduling Won't Save Them—Or Will, Too Late

Photo by Rebekah Roy via Unsplash.

Trump's December 18, 2025 executive order directed the federal government to initiate the process of downgrading cannabis from Schedule I to Schedule III under the Controlled Substances Act. This was, on its face, a significant signal. But as of Q1 2026, the administrative rescheduling process remained in motion with no formal relief granted to cannabis operators. The executive order set the direction, but the actual mechanism—a formal DEA rulemaking and potential congressional action—was still months away at minimum, and possibly years away if political momentum stalled.

This matters because cannabis operators and their creditors are operating under Section 280E of the tax code, a rule dating to 1982 that prohibits deduction of cost of goods sold for businesses trafficking in Schedule I or Schedule II controlled substances. Rescheduling to Schedule III would remove that prohibition, and operators estimate the tax benefit at 15-20 percent of after-tax cash flow industry-wide. That is material money—the difference between 8 percent operating margins and 10 percent or better. But rescheduling is not an executive action; it requires formal administrative process or congressional relief. The December 2025 order did not trigger Section 280E relief. It just signaled direction.

Operators who went into refinancing talks in late 2025 and early 2026 had to decide whether to assume the tax benefit would materialize in time to improve their refinancing terms. Most lenders said no. FiSai, a major cannabis lender that had funded Columbia Care (now The Cannabist Co.), explicitly warned against a pray and hope strategy tied to rescheduling or political change. The message from lenders was clear: we will not assume federal relief that might not materialize, and we will not price debt as if Section 280E gets repealed before maturity. Operators had to refinance under the current tax code, with current cash flow, on current terms.

Even if rescheduling passes in late 2026 or 2027—a plausible timeline given administrative processes—operators who refinanced in early 2026 have already locked in their cost of debt through maturity. Curaleaf's 11.5 percent coupon on $500 million of 2026-issued notes does not reset downward if Section 280E relief arrives in 2027. The tax benefit, when it comes, arrives too late to repair balance sheets already hollowed by five years of 11 percent debt service. Early refinancers are betting that they survive debt service costs long enough to reach a moment when higher cash flow actually improves their financial position. But that moment might not arrive until 2030-2031, well after their next refinancing deadline.

This creates a structural lag that paradoxically favors the operators who refinanced earliest and most painfully. Curaleaf paid 11.5 percent to refinance in February 2026, but that same Curaleaf will have generated years of operating cash flow by 2029-2030. Operators who refinance in late 2026 or early 2027 will do so at rates that might be slightly lower (because Section 280E relief is now in effect), but they will have lost months or years of compressed cash flow during the transition. The market is not efficient here—it is punishing those who wait, even if the economic case for waiting (that rescheduling will improve terms) is theoretically sound. Lenders have priced in zero assumption of relief, and operators have to match that price.

What Comes After the Shakeout: The Consolidated Play

Photo by George Morina via Pexels.

The shakeout is not going to result in a single, industry-dominant operator. It will result in a smaller number of larger operators, each with higher debt loads and tighter operational constraints, competing in a less fragmented retail landscape. The winners of this process will not be those with the best business models or most innovative products. They will be those with access to debt capital on acceptable terms, and the operational discipline to service that debt while competitors are failing.

Creditor-owned NewCos—entities like the Ayr acquisition vehicle that emerge after foreclosure—operate under a fundamentally different mandate than equity-owned operators. Their first priority is debt paydown, not growth. That means smaller operating budgets, tighter labor discipline, and lower capital expenditure on new licenses or expanded capacity. A NewCo will be profitable and efficient, but it will not be aggressive. It will hold market share rather than acquire it. Over time, as these NewCos pay down debt, they will become attractive acquisition targets for larger, equity-rich operators looking to consolidate cash flow and reduce the total operator count in fragmented state markets.

The early refinancers—Curaleaf, Jushi, Verano—retain equity control and operational flexibility, but they carry much higher debt service costs than they did in 2023-2024. That creates an incentive to grow operating cash flow faster than debt grows. The way to do that in a mature market is not organic growth; it is consolidation. Curaleaf, already the largest retailer, will be incentivized to acquire smaller operators and fold their cash flows into its balance sheet. Each acquisition improves Curaleaf's debt ratios slightly, even if it does not reduce absolute debt. This dynamic will accelerate M&A across the sector, particularly at state lines where smaller operators with strong local positions but no capital access become acquisition targets.

Cannabis lenders have now demonstrated that they will foreclose and transfer ownership if operators miss refinancing windows. That precedent will reshape how future operators and lenders interact. Operators entering 2027-2028 will face tighter covenants in their debt agreements—explicit requirements around minimum cash flow, maximum leverage ratios, and quarterly compliance reporting. The days of loose covenant packages are over. Lenders will demand asset-based lending structures where they can seize collateral within weeks, not months. Operators who miss targets will trigger immediate default, not a grace period for negotiation. This is a structural shift from the Wild West financing environment of 2021-2023 toward a tighter, more banker-like discipline.

The net effect will be a compression of the operator base. There are currently around 20 significant MSOs competing for market share across state lines. After this shakeout runs its course—through late 2026 and into 2027—that number will likely compress to 10-12 major players. Some will be wiped out in foreclosures. Others will merge with larger competitors to avoid refinancing risk. A few will be acquired by private equity sponsors or existing operators looking to consolidate. The survivors will be larger, more efficient, carry more debt, and face tighter financial constraints. But they will own themselves, or they will be owned by creditors with a clear paydown mandate.

State-level consolidation will accelerate this process. In states with fragmented retail markets—California, Illinois, Massachusetts—equity-rich operators or NewCos with fresh capital will acquire distressed franchises at discounts well below their pro-forma cash flow multiples. A state regulator sees a consolidation from 50 operators to 35, but that consolidation was not driven by policy; it was driven by balance sheet pressure. The survivors in each state will have lower costs of capital and better access to financing because they survived the shakeout. That advantage compounds over time, widening the gap between consolidated players and smaller regional operators who missed the refinancing window.

The debt wall through 2026 is not a crisis waiting to happen. It is a sorting mechanism actively happening, and Ayr Wellness' November 2025 foreclosure and creditor takeover proved the mechanism works. This outcome was baked into the financing structure the moment operators chose to fund 80 percent of capital raises with debt instead of equity, and the moment federal prohibition eliminated bankruptcy protection as a pressure valve. When operators cannot file Chapter 11 to reorganize, they can only refinance or lose ownership. When debt is the only capital source, refinancing becomes mandatory. When interest rates rise and debt maturity walls arrive, the mandatory refinancing occurs at worse terms. The logic was deterministic from the start.

\n\n

The survivors of this shakeout will not be the operators with the most licenses or the largest cultivation footprint. They will be the operators who refinanced early, who accepted 11-12 percent interest rates as the cost of remaining independent, and who have the operational discipline to service that debt while competitors are being foreclosed. Curaleaf at 11.5 percent, Jushi at 12.5 percent—these painful rates buy something valuable: control through 2028-2029, and a runway to prove that cannabis operations can generate enough cash flow to justify high debt costs.

\n\n

Operators who waited—Cresco Labs in August 2026, Trulieve later that year—face a narrowing window where refinancing remains possible but becomes increasingly uncertain. Miss that window, and UCC foreclosure becomes the mechanism: asset seizure, equity wipeout, and transfer to creditors. That is not a scenario; it is what is happening to Ayr, and it will happen to others who miscalculate their cash flow or the timing of regulatory relief.

\n\n

The next 18 months will sort the industry not by business model or market innovation or product quality, but by balance sheet discipline and lender relationships. That is an unusual sorting mechanism for a maturing cannabis market—most industries consolidate around the operators with the best execution and the strongest competitive advantages. But cannabis is structured by federal prohibition and tax code, not just by consumer preference. The shakeout will produce a smaller, more leveraged, more tightly managed industry. Whether that produces better outcomes for consumers and investors depends on what happens after—whether the survivors use their consolidated positions to invest in innovation, or whether they simply become debt-service machines designed to generate quarterly cash flow for lender paydown. That question remains open. But the sorting itself is no longer hypothetical. It is already underway.

Browse our seed collection.